Korean J Parasitol.  2006 Dec;44(4):361-366. 10.3347/kjp.2006.44.4.361.

Therapeutic evaluation of sustained-releasing praziquantel (SRP) for clonorchiasis: Phase 1 and 2 clinical studies

Affiliations
  • 1Department of Parasitology and Tropical Medicine and Institute of Endemic Diseases, Seoul National University College of Medicine, Seoul, 110-799, Korea. hst@snu.ac.kr
  • 2Department of Pharmacology, Ewha Womans University College of Pharmacy, Seoul 120-750, Korea.
  • 3Department of Pharmacology and Clinical Trial Center, Seoul National University College of Medicine, Seoul 110-799, Korea.
  • 4Department of Parasitology, Inje University College of Medicine, Busan 614-735, Korea.
  • 5Department of Preventive medicine, Inje University College of Medicine, Busan 614-735, Korea.

Abstract

Sustained-releasing praziquantel (SRP) tablet was designed for single dose treatment regimen of clonorchiasis. A previous pre-clinical study confirmed its sustained-releasing characteristics and a better cure rate than conventional praziquantel (PZQ). In this clinical study, the pharmacokinetics of this SRP tablet were investigated in human volunteers (phase 1; 12 volunteers), and its curative efficacy was examined in clonorchiasis patients (phase 2; 20 volunteers). In the phase 1 clinical study, blood concentrations of both tablets showed wide individual variation. The AUC(last) of SRP was 497.9+/-519.0 ng.hr/ml (mean+/-SD) and PZQ of 628.6+/-695.5 ng.hr/ml, and the AUC(inf) of SRP was 776.0+/-538.5 ng.hr/ml and of PZQ 658.6+/-709.9 ng.hr/ml. C(max) values of SRP and PZQ were 90.7+/-82.2 ng/ml and 214.9+/-251.9 ng/ml, and T(max) values were 3.42+/-1.43 hr and 1.96+/-1.23 hr, respectively. SRP tablets showed similar AUC values, but lower C(max) and longer T(max) values than PZQ. In the phase 2 study, SRP at 30 mg/kg (single dose) achieved a 60% cure rate and a 95.5% egg reduction rate. The cure rate of a single dose SRP was unsatisfactory compared with that of the conventional PZQ dose, but much better than that achieved by a single dose PZQ.

Keyword

Clonorchis sinensis; clonorchiasis; clinical study; human; praziquantel; sustained-release; cure rate

MeSH Terms

*Praziquantel/adverse effects/pharmacokinetics/therapeutic use
Parasite Egg Count
Male
Humans
*Delayed-Action Preparations/pharmacokinetics/therapeutic use
Clonorchis sinensis/*drug effects/isolation & purification
Clonorchiasis/*drug therapy
Area Under Curve
*Anthelmintics/adverse effects/pharmacokinetics/therapeutic use
Animals
Adult
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr